Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Knuf

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
MMW Fortschritte Der Medizin|September 29, 2011
[Consensus report. Recommendations for the upcoming influenza vaccination season]Thomas Weinke, Barbara Gärtner, Markus Knuf, et al.
Expert Review of Vaccines|August 29, 2023
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad contextGiacomo Casabona, Olivia Berton, Tina Singh, et al.
Expert Review of Vaccines|May 2, 2024
Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccinationCynthia Burman, Markus Knuf, Marco Aurelio P Sáfadi, et al.
Mycoses|July 23, 2008
Rapid detection of common pathogenic Aspergillus species by a novel real-time PCR approachJoerg Faber, Nikola Moritz, Nicole Henninger, et al.
Frontiers in Medicine|September 15, 2022
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatmentsMarie Monaghan, Pooja Takhar, Luke Langlands, et al.
Klinische Padiatrie|June 6, 2020
Management of Care for Neonates Born to SARS-CoV-2 Positive Women with or without Clinical Symptoms (COVID-19)Arne Simon, Johannes Hübner, Markus Knuf, et al.
Human Vaccines & Immunotherapeutics|February 19, 2021
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccinesLidia Serra, Markus Knuf, Federico Martinón-Torres, et al.
Human Vaccines & Immunotherapeutics|April 10, 2012
Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young childrenMarkus Knuf, Yaela Baine, Veronique Bianco, et al.
Vaccine|May 5, 2018
Antibody persistence and booster response 68 months after vaccination at 2-10 years of age with one dose of MenACWY-TT conjugate vaccineMarkus Knuf, Klaus Helm, Devayani Kolhe, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 11, 2008
A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal diseaseJoerg Faber, Nicole Henninger, Adam Finn, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
MMW Fortschritte Der Medizin|September 29, 2011
[Consensus report. Recommendations for the upcoming influenza vaccination season]Thomas Weinke, Barbara Gärtner, Markus Knuf, et al.
Expert Review of Vaccines|August 29, 2023
Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad contextGiacomo Casabona, Olivia Berton, Tina Singh, et al.
Expert Review of Vaccines|May 2, 2024
Antibody persistence and revaccination recommendations of MenACWY-TT: a review of clinical studies assessing antibody persistence up to 10 years after vaccinationCynthia Burman, Markus Knuf, Marco Aurelio P Sáfadi, et al.
Mycoses|July 23, 2008
Rapid detection of common pathogenic Aspergillus species by a novel real-time PCR approachJoerg Faber, Nikola Moritz, Nicole Henninger, et al.
Frontiers in Medicine|September 15, 2022
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatmentsMarie Monaghan, Pooja Takhar, Luke Langlands, et al.
Klinische Padiatrie|June 6, 2020
Management of Care for Neonates Born to SARS-CoV-2 Positive Women with or without Clinical Symptoms (COVID-19)Arne Simon, Johannes Hübner, Markus Knuf, et al.
Human Vaccines & Immunotherapeutics|February 19, 2021
Review of clinical studies comparing meningococcal serogroup C immune responses induced by MenACWY-TT and monovalent serogroup C vaccinesLidia Serra, Markus Knuf, Federico Martinón-Torres, et al.
Human Vaccines & Immunotherapeutics|April 10, 2012
Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young childrenMarkus Knuf, Yaela Baine, Veronique Bianco, et al.
Vaccine|May 5, 2018
Antibody persistence and booster response 68 months after vaccination at 2-10 years of age with one dose of MenACWY-TT conjugate vaccineMarkus Knuf, Klaus Helm, Devayani Kolhe, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 11, 2008
A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal diseaseJoerg Faber, Nicole Henninger, Adam Finn, et al.
Pageof 12